A newly published article in the Journal of the National Cancer Institute has suggested that men carrying a particular genetic mutation in the kallikrein 6 gene (KLK-6) have an increased risk for aggressive, clinically significant prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: aggressive, genetic, kallikrein, KLK-6, mutation, risk | 2 Comments »
Data from a large study reported in the July issue of the Journal of the National Cancer Institute has confirmed the potential ability of a four-kallikrein marker test to lower the need for biopsies in men at risk for prostate cancer while delaying diagnosis of high-grade cancers in a few men. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: Diagnosis, grade, kallikrein, risk | 2 Comments »
According to data from a large, prospective, multi-institutional trial carried out here in the USA, the 4KScore test has shown a high degree of ability to accurately identify men with a Gleason score of 3 + 4 = 7 or higher which was subsequently confirmed on prostate biopsy. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: 4Kscore, accuracy, Diagnosis, kallikrein, risk, test | 4 Comments »
According to a media release on the company’s web site, OPKO Health has completed the acquisition of Prost-Data, Inc. (otherwise known to many prostate cancer patients and support group leaders — as well as their urologists — as Jonathon Oppenheimer’s independent uropathology company OURLab). … READ MORE …
Filed under: Diagnosis, Risk | Tagged: 4Kscore, Diagnosis, kallikrein, OPKO, OurLab, PSA, risk, test | 1 Comment »
The collaborative research between the teams at Memorial Sloan-Kettering Cancer Center in New York and in Malmö in Sweden continues to refine a model that may allow us to accurately predict which patients are at clinically significant risk for prostate cancer based solely on simple tests run on a single blood sample. … READ MORE …
Filed under: Diagnosis, Risk, Uncategorized | Tagged: biopsy, clinically significant, kallikrein, prediction, PSA, risk | Leave a comment »
In 2008, Vickers et al. initially proposed that a panel of four kallikrein markers, together with patient age, could potentially reduce the need for unnecessary biopsies in previously untested men with an elevated PSA level and a theoretical risk for prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: early detection, kallikrein, PSA | 2 Comments »
Today’s news reports include comments on studies dealing with:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: castration-resistant prostate cancer, CRPC, kallikrein, open, prognosis, prostatectomy, quality of life, RALP, risk, robot-assisted, survival | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 